Many supplements are available to the general public for a limited time on our SuppleNet page.
VOLUME 62 2001 SUPPLEMENT 9
Articles
3 Introduction: Evaluating Clinical Trial Data From
Schizophrenia Research. Carol A. Tamminga
[PDF]
5 Hypothesis and Hypothesis Testing in the Clinical Trial. Jeffrey
A. Lieberman
[Abstract]
[PDF]
11 Evaluating Characteristics of Patient Selection and Dropout
Rates. Samuel J. Keith
[Abstract]
[PDF]
17 Clinical Trial Design Issues in Schizophrenic Research. Daniel
E. Casey
[Abstract]
[PDF]
23 Evaluating Clinical Trial Data: Outcome Measures. Robert
R. Conley
[Abstract]
[PDF]
29 Dose Selection and Comparator Drugs in Schizophrenia
Research. John M. Kane
[Abstract]
[PDF]
35 The Statistical Comparison of Clinical Trials. Nina R.
Schooler
[Abstract]
[PDF]
40 Interpretations and Conclusions in the Clinical Trial. John
P. Docherty
[Abstract]
[PDF]
44 Concluding Discussion.
[PDF]
CME Section
46 Instructions and Posttest.
[PDF]
48 CME Registration and Evaluation.
[PDF]